← Leaderboards
Robert A Burger
University Of California Irvine
$607,680
Attributed
$607,680
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $121.4K · FY2005–06$200K$150K$100K$50K$0
'05
'06
Funding mix
By agency
NIH$607,680 · 2
By mechanism
K23$607,680 · 1
P30$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Irvine
Same institution · by research overlap
- Hoda A. Anton-Culver$54,419,850
- Frank Louis Meyskens$19,843,890
- Charles Joseph Gomer$5,568,369
- Murray Korc$11,956,061
- Marian L Waterman$14,719,777
Others in their field
Top investigators on “Neoplastic Process”
- David Heimbrook · Leidos Biomedical Research, Inc.$112,211,212
- Michael S. Saag · University Of Alabama At Birmingham$32,218,304
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Mary Kay Washington · Vanderbilt University$24,250,359
- David Sidransky · Johns Hopkins University$21,962,468
- Bruce W Stillman · Cold Spring Harbor Laboratory$21,647,002
Research focus
Neoplastic ProcessNeoplasm /Cancer ChemotherapyAntineoplasticsAntisense Nucleic AcidWomen'S HealthAngiogenesis InhibitorsLaboratory RatMagnetic Resonance ImagingNonhuman Therapy EvaluationOvary NeoplasmsPatient Oriented ResearchTransfectionVascular Endothelial Growth FactorsAngiogenesisComplementary DnaFemaleHuman SubjectHuman Therapy EvaluationClinical ResearchClinical Trial Phase IiNeoplasm /CancerData ManagementCancer Information SystemHealth Science Research Support
Grant awards (7)
Angiogenesis Targeted Therapeutics of Ovarian Cancer$60,808
K23 · FY2006 · CA · contact PI
Angiogenesis Targeted Therapeutics of Ovarian Cancer$121,365
K23 · FY2005 · CA
Angiogenesis Targeted Therapeutics of Ovarian Cancer$121,436
K23 · FY2004 · CA
Angiogenesis Targeted Therapeutics of Ovarian Cancer$121,557
K23 · FY2003 · CA
Angiogenesis Targeted Therapeutics of Ovarian Cancer$60,811
K23 · FY2002 · CA
CORE--CLINICAL RESEARCH OFFICE$0
P30 · FY2002 · CA
Angiogenesis Targeted Therapeutics of Ovarian Cancer$121,703
K23 · FY2001 · CA